Eli Lilly (LLY) Return on Invested Capital (2009 - 2026)

Eli Lilly (LLY) has reported Return on Invested Capital for 18 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.0%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (down 1.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.0% for Q1 2026 at Eli Lilly, up from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.09% in Q2 2025 and troughed at 0.0% in Q4 2025.
• Average Return on Invested Capital over 5 years is 0.01%, with a median of 0.01% recorded in 2023.
• The widest YoY moves for Return on Invested Capital: up 8 bps in 2025, down 1 bps in 2025.
• Over 5 years, Return on Invested Capital stood at 0.01% in 2022, then soared by 56 bps to 0.01% in 2023, then rose by 7 bps to 0.01% in 2024, then sank by 68 bps to 0.0% in 2025, then gained by 9 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.